Brief: Can-Fite Biopharma Says Entered Into Agreement For Purchase & Sale Of 5 Mln ADSs
12/08/2021 13:22
Aug 12 (Reuters) - Can-Fite Biopharma Ltd CANF.TA :
* CAN FITE BIOPHARMA - ENTERED INTO DEFINITIVE AGREEMENT FOR
PURCHASE & SALE OF 5 MILLION OF CO'S ADSS AT AN EFFECTIVE
PURCHASE PRICE OF $2.00/ADS
Source text for Eikon: ID:nBw820MRWa
Further company coverage: CANF.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Can Fite Biopharma
See all newsBrief: Corrected-Can Fite Biopharma Ltd Files For Offering Of Up To 6.6 mln Ordinary Shares By Selling Shareholders
Can-Fite BioPharma rises after longer-than-anticipated overall survival in ongoing liver cancer study
Can-Fite BioPharma reports longer-than-anticipated overall survival in ongoing liver cancer study
Brief: Can Fite Biopharma Can-Fite Submits Phase 2 Study Protocol For Piclidenoson In Lowe Syndrome
Can-Fite rises as skin drug study reaches interim analysis stage